The Yong Loo Lin School of Medicine, National University of Singapore (NUS Medicine) and Robert Koch Institute (RKI), Berlin, Germany have entered a strategic partnership with the signing of a Memorandum of Understanding (MoU) to collaborate on joint operations in scientific, academic and training initiatives, focusing on pandemic preparedness and public health.
This partnership marks a significant step forward in leveraging the strengths of both institutions to promote innovation, knowledge exchange, and applied research in advancing biomedical and public health research and training for combating biological threats and improving population health.
The collaboration aims to enhance capacity building, develop cutting-edge solutions, and support sustainable practices through collaborative research and shared operational frameworks.
Key areas of cooperation outlined in the agreement include:
The initial areas of focus will centre on high-containment infectious disease research, with a particular emphasis on training, benchmarking of biorisk management systems, and sharing of operational expertise in BSL-3 and BSL-4 laboratory environments. To date, two exploratory visits by NUS Medicine BSL-3 Core Facility staff to RKI have taken place, involving site tours and seminar exchanges aimed at identifying joint research opportunities and operational synergies.
